Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

EVT-302 for smoking cessation begins clinical testing

March 26, 2007

Cleveland BioLabs to submit Protectan CBLB-502 in response to RFP

March 23, 2007

GTC grants expanded license to PharmAthene in support of Protexia

March 15, 2007

Enrollment complete in phase I/II study of ALKS-29 in alcohol dependence

March 8, 2007

Extended-release QuitPak begins pilot study for smoking cessation

Feb. 12, 2007

Virginia Commonwealth University and Nicogen jointly divulge novel antismoking agents

Feb. 6, 2007

Canadian approval for Champix

Jan. 29, 2007

Suboxone available in U.K.

Jan. 26, 2007

ADX-10061 begins proof-of-concept study for smoking cessation

Jan. 26, 2007

elbion acquires product candidates from DrugAbuse Sciences

Jan. 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...